Diphenylcyclopropenone and platelet‐rich plasma in the management of severe or recalcitrant alopecia areata
Journal of Cosmetic Dermatology · 2023-11 · 22 (11) · 2971-2981
DOI: 10.1111/jocd.15805 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Cosmetic Dermatology, online erschienen am 14.06.2023. Verfasst von Wafaa Mohamed Abd El-Magid und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Venereology and Andrology, Faculty of Medicine, Sohag University, Sohag, Egypt. Hauptthemen laut MEDLINE: Alopecia Areata, Platelet-Rich Plasma, Cyclopropanes. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Alopecia areata (AA) is a common disease characterized by hair loss with an autoimmune background. There are many lines of therapy, but no standard line for all cases. Consequently, treating severe forms of AA is challenging.
Objective
This study aimed to compare the efficacy and safety of the combination of diphenylcyclopropenone (DPCP) and platelet‐rich plasma (PRP) with DPCP alone in treating patients with severe or refractory AA. Patients and methods Our randomized clinical trial was conducted on patients with severe and recalcitrant AA. Group A included 13 patients who received only DPCP, while Group B included 11 patients who received both DPCP and PRP. After sensitization in both groups of patients, DPCP was applied to half the scalp weekly. In addition, PRP injection in all scalp was performed once a month in group B. The patients in both groups completed the study for six months.
Results
The regrowth scale results were 53.85% and 54.5% for groups A and B, respectively. Although the response rate of group B was higher than that of group A, there is no statistically significant difference between the two groups.
Conclusion
From our clinical trial, it can be concluded that DPCP alone or combined with PRP is an effective and safe method for treating severe or recalcitrant AA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Venereology and Andrology, Faculty of Medicine, Sohag University, Sohag, Egypt.
- Dermatology, Venerology and Andrology Medical Administration, Sohag University, Sohag, Egypt.
ORCID-Profile: Wafaa Mohamed Abd El-Magid
Zitieren
APA
Abd El-Magid, W. M., Mohamed, R. A., & Elsharkawy, R. E. (2023). Diphenylcyclopropenone and platelet‐rich plasma in the management of severe or recalcitrant alopecia areata. Journal of Cosmetic Dermatology, 22(11), 2971-2981. https://doi.org/10.1111/jocd.15805
Vancouver
Abd El-Magid WM, Mohamed RA, Elsharkawy RE. Diphenylcyclopropenone and platelet‐rich plasma in the management of severe or recalcitrant alopecia areata. Journal of Cosmetic Dermatology. 2023;22(11):2971-2981. doi:10.1111/jocd.15805
BibTeX
@article{AbdElMagid2023,
author = {Abd El-Magid, Wafaa Mohamed and Mohamed, Raghda Alaa-Eldeen and Elsharkawy, Reham Ezz-Eldawla},
title = {Diphenylcyclopropenone and platelet‐rich plasma in the management of severe or recalcitrant alopecia areata},
journal = {Journal of Cosmetic Dermatology},
year = {2023},
volume = {22},
number = {11},
pages = {2971--2981},
doi = {10.1111/jocd.15805}
}
EUVIMED